Point72 Asset Management L.P. Buys New Holdings in agilon health, inc. (NYSE:AGL)

Point72 Asset Management L.P. bought a new position in shares of agilon health, inc. (NYSE:AGL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 404,299 shares of the company's stock, valued at approximately $768,000. Point72 Asset Management L.P. owned about 0.10% of agilon health at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the company. Capital International Investors raised its holdings in shares of agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC increased its position in agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after buying an additional 4,706,357 shares during the last quarter. Algert Global LLC raised its stake in agilon health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after buying an additional 1,924,157 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after buying an additional 1,498,524 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC bought a new position in shares of agilon health during the 4th quarter worth approximately $1,616,000.

agilon health Trading Up 3.4%

NYSE AGL traded up $0.08 on Wednesday, reaching $2.31. The company had a trading volume of 924,775 shares, compared to its average volume of 4,934,537. The firm has a market cap of $954.57 million, a price-to-earnings ratio of -2.46 and a beta of 0.38. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The business has a 50 day moving average of $3.92 and a two-hundred day moving average of $3.18. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same period last year, the company earned ($0.02) earnings per share. The firm's revenue was down 4.5% compared to the same quarter last year. Analysts forecast that agilon health, inc. will post -0.59 EPS for the current year.

Analysts Set New Price Targets

AGL has been the subject of several research reports. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a report on Friday, March 21st. The Goldman Sachs Group lifted their target price on shares of agilon health from $2.50 to $5.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Royal Bank of Canada increased their price target on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Cowen restated a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Finally, TD Cowen increased their target price on agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $4.79.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.